gadolinium dtpa has been researched along with capecitabine in 1 studies
| Studies (gadolinium dtpa) | Trials (gadolinium dtpa) | Recent Studies (post-2010) (gadolinium dtpa) | Studies (capecitabine) | Trials (capecitabine) | Recent Studies (post-2010) (capecitabine) |
|---|---|---|---|---|---|
| 12,654 | 664 | 4,051 | 5,318 | 1,719 | 3,282 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, X; Wang, Y; Xing, J; Zhang, Z; Zhao, H; Zhou, M; Zhou, X; Zhou, Y | 1 |
1 other study(ies) available for gadolinium dtpa and capecitabine
| Article | Year |
|---|---|
Rim enhancement on hepatobiliary phase of pre-treatment 3.0 T MRI: A potential marker for early chemotherapy response in colorectal liver metastases treated with XELOX.
Topics: Antineoplastic Combined Chemotherapy Protocols; Capecitabine; Colorectal Neoplasms; Contrast Media; Gadolinium DTPA; Humans; Liver; Liver Neoplasms; Magnetic Resonance Imaging; Oxaloacetates; Retrospective Studies | 2021 |